Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lars Aabakken. (2008) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 43:7, pages 771-773.
Read now
Read now
Articles from other publishers (33)
Roberto Ponce-Pincay & Callejas Diana. (2023) Reactivación y coinfecciones virales en COVID-19: otro elemento a considerar. Revisión Sistemática. Kasmera 51.
Crossref
Crossref
Jacky C. L. Ho, Joyce W. Y. Mak, Terry C. F. Yip, Hong Man Lam, Tsz Yan Cheng, Tsz On Lam, Lai Shan Tam, Man Fai Law, Carmen K. M. Cheung, Siew C. Ng, Vincent W. S. Wong & Grace L. H. Wong. (2022) Risk of alanine aminotransferase flare in patients with previous hepatitis B virus exposure on biological modifier therapies—A population‐based study. Liver International 43:3, pages 588-598.
Crossref
Crossref
Ting Ting ChanWah Kheong ChanGrace Lai-Hung WongAnthony Wing-Hung ChanNik Raihan Nik MustaphaStephen Lam ChanCharing Ching-Ning ChongSanjiv MahadevaSally She-Ting ShuPaul Bo-San LaiHenry Lik-Yuen ChanVincent Wai-Sun Wong. (2020) Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. American Journal of Gastroenterology 115:6, pages 867-875.
Crossref
Crossref
Yutaka Midorikawa, Tadatoshi Takayama, Hisashi Nakayama, Tokio Higaki, Masamichi Moriguchi, Kyoji Moriya, Tatsuo Kanda, Shunichi Matsuoka & Mitsuhiko Moriyama. (2019) Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma. BMC Gastroenterology 19:1.
Crossref
Crossref
Kenji Tatsuno, Yutaka Midorikawa, Tadatoshi Takayama, Shogo Yamamoto, Genta Nagae, Mitsuhiko Moriyama, Hayato Nakagawa, Kazuhiko Koike, Kyoji Moriya & Hiroyuki Aburatani. (2019) Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection. Clinical Cancer Research 25:20, pages 6217-6227.
Crossref
Crossref
Hanan Omar, Samaa Taha, Wafaa Hassan & Hamdy Omar. (2018) Occult hepatitis B infection: a hidden factor of poor response to intervention treatment of hepatocellular carcinoma in chronic hepatitis C patients. Comparative Clinical Pathology 27:5, pages 1273-1279.
Crossref
Crossref
H. Wang, R. Swann, E. Thomas, H. A. Innes, H. Valerio, P. C. Hayes, S. Allen, S. T. Barclay, D. Wilks, R. Fox, D. Bhattacharyya, N. Kennedy, J. Morris, A. Fraser, A. J. Stanley, R. Gunson, P. G. Mclntyre, A. Hunt, S. J. Hutchinson, P. R. Mills & J. F. Dillon. (2018) Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population‐level analysis. Journal of Viral Hepatitis 25:8, pages 930-938.
Crossref
Crossref
Man-Fung Yuen. 2018. Hepatitis B Virus and Liver Disease. Hepatitis B Virus and Liver Disease
297
313
.
Lal Arjun, Kumar Ajay, Nag Sanjay, Rajpal Kamlesh & Mahto Sushil Prasad. (2017) PREVALENCE OF HEPATITIS B INFECTION IN A TERTIARY CARE HOSPITAL IN BIHAR. Journal of Evolution of Medical and Dental Sciences 6:89, pages 6189-6191.
Crossref
Crossref
Hirohito Shimizu, Keiji Matsui, Shogo Iwabuchi, Tomoaki Fujikawa, Mitsuru Nagata, Kentaro Takatsuka, Hiroyuki Tanemura, Haruhiro Nakazaki, Masayuki Nakano & Tsunamasa Watanabe. (2017) Relationship of hepatitis B virus infection to the recurrence of hepatocellular carcinoma after direct acting antivirals. Indian Journal of Gastroenterology 36:3, pages 235-238.
Crossref
Crossref
Nematollah Jonaidi-Jafari, Mohammad Saeid Rezaee-Zavareh, Javad Tavallaei-Nosratabadi, Reza Ajudani, Mahdi Ramezani-Binabaj, Hamidreza Karimi-Sari, Morteza Izadi, Reza Ranjbar, Seyyed Mohammad Miri & Seyed Moayed Alavian. (2016) Occult Hepatitis B Infection in Hepatitis C Patients with Hematological Disorders. Jundishapur Journal of Microbiology 10:2.
Crossref
Crossref
Nicola Coppola, Lorenzo Onorato, Caterina Sagnelli, Evangelista Sagnelli & Italo F. Angelillo. (2016) Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease. Medicine 95:30, pages e4311.
Crossref
Crossref
Junhyeon Cho, Sang Soo Lee, Yun Suk Choi, Yejoo Jeon, Jung Wha Chung, Joo Yeong Baeg, Won Keun Si, Eun Sun Jang, Jin-Wook Kim & Sook-Hyang Jeong. (2016) Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection. World Journal of Gastroenterology 22:42, pages 9427.
Crossref
Crossref
Guanghua Rong, Hong Wang, Christopher L. Bowlus, Chunping Wang, Yinying Lu, Zhen Zeng, Jianhui Qu, Min Lou, Yan Chen, Linjing An, Yongping Yang & M. Eric Gershwin. (2015) Incidence and Risk Factors for Hepatocellular Carcinoma in Primary Biliary Cirrhosis. Clinical Reviews in Allergy & Immunology 48:2-3, pages 132-141.
Crossref
Crossref
Nicola Coppola. (2015) Role of occult hepatitis B virus infection in chronic hepatitis C. World Journal of Gastroenterology 21:42, pages 11931.
Crossref
Crossref
Bouchra Kitab, Sayeh Ezzikouri, Rhimo Alaoui, Salwa Nadir, Wafaa Badre, Christian Trepo, Isabelle Chemin & Soumaya Benjelloun. (2014)
Occult
HBV
infection in Morocco: from chronic hepatitis to hepatocellular carcinoma
. Liver International 34:6.
Crossref
Crossref
X. Huang & F. B. Hollinger. (2014) Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review. Journal of Viral Hepatitis 21:3, pages 153-162.
Crossref
Crossref
Alicja E. Grzegorzewska, Piotr M. Wobszal, Anna Sowińska, Adrianna Mostowska & Paweł P. Jagodziński. (2013) Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection. Molecular Biology Reports 40:12, pages 6899-6911.
Crossref
Crossref
MASAHITO NAKANO, TAKUMI KAWAGUCHI, SHINGO NAKAMOTO, ATSUSHI KAWAGUCHI, TATSUO KANDA, FUMIO IMAZEKI, RYOKO KUROMATSU, SHUJI SUMIE, MANABU SATANI, SHINGO YAMADA, TAKUJI TORIMURA, TATSUYUKI KAKUMA, OSAMU YOKOSUKA & MICHIO SATA. (2013) Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection. Oncology Reports 30:5, pages 2049-2055.
Crossref
Crossref
Naoko Tsubouchi, Hirofumi Uto, Kotaro Kumagai, Fumisato Sasaki, Shuji Kanmura, Masatsugu Numata, Akihiro Moriuchi, Makoto Oketani, Akio Ido, Katsuhiro Hayashi, Kazunori Kusumoto, Kazuya Shimoda, Sherri O. Stuver & Hirohito Tsubouchi. (2013)
Impact of antibody to hepatitis
B
core antigen on the clinical course of hepatitis
C
virus carriers in a hyperendemic area in
J
apan: A community‐based cohort study
. Hepatology Research 43:11, pages 1130-1138.
Crossref
Crossref
Giovanni Squadrito, Irene Cacciola, Angela Alibrandi, Teresa Pollicino & Giovanni Raimondo. (2013) Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C. Journal of Hepatology 59:4, pages 696-700.
Crossref
Crossref
Shereen E. Taha, Soha A. El-Hady, Tamer M. Ahmed & Iman Z. Ahmed. (2013) Detection of occult HBV infection by nested PCR assay among chronic hepatitis C patients with and without hepatocellular carcinoma. Egyptian Journal of Medical Human Genetics 14:4, pages 353-360.
Crossref
Crossref
Loredana Covolo, Teresa Pollicino, Giovanni Raimondo & Francesco Donato. (2013) Occult hepatitis B virus and the risk for chronic liver disease: A meta-analysis. Digestive and Liver Disease 45:3, pages 238-244.
Crossref
Crossref
Jae Young JangEui Ju Park. (2013) Occult Hepatitis B Virus Infection in Chronic Hepatitis C. The Korean Journal of Gastroenterology 62:3, pages 154.
Crossref
Crossref
G.Y. Minuk, K. Kowalec, S. Caouette, B. Larke & C. Osiowy. (2012) The prevalence and long term outcome of occult hepatitis B virus infections in community based populations. Journal of Medical Virology 84:9, pages 1369-1375.
Crossref
Crossref
Yuko Nagaoki, Hideyuki Hyogo, Hiroshi Aikata, Mio Tanaka, Noriaki Naeshiro, Takashi Nakahara, Yoji Honda, Daisuke Miyaki, Tomokazu Kawaoka, Shintaro Takaki, Akira Hiramatsu, Koji Waki, Michio Imamura, Yoshiiku Kawakami, Shoichi Takahashi & Kazuaki Chayama. (2011) Recent trend of clinical features in patients with hepatocellular carcinoma. Hepatology Research 42:4, pages 368-375.
Crossref
Crossref
Yu Shi, Yi Hua Wu, Wei Wu, Wan Jun Zhang, Jun Yang & Zhi Chen. (2011) Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta‐analysis. Liver International 32:2, pages 231-240.
Crossref
Crossref
Mohammad Kazemi Arababadi, Gholamhossein Hassanshahi, Ali Akbar Pourfathollah, Ebrahim Rezazadeh Zarandi & Derek Kennedy. (2011) Post-Transfusion Occult Hepatitis B (OBI): A Global Challenge for Blood Recipients and Health Authorities. Hepatitis Monthly 11:9, pages 714-718.
Crossref
Crossref
Anna S. Lok, James E. Everhart, Adrian M. Di Bisceglie, Hae-Young Kim, Munira Hussain & Timothy R. Morgan. (2011) Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology 54:2, pages 434-442.
Crossref
Crossref
A. E. Grzegorzewska, V. Kaczmarek-Leki, M. Mlot-Michalska & L. Niepolski. (2010) Seroconversion rate to positivity for antibodies against core antigen of hepatitis B virus and duration of renal replacement therapy. Nephrology Dialysis Transplantation 26:3, pages 970-976.
Crossref
Crossref
Tokihiko Sawada, Keiichi Kubota, Junji Kita, Masato Kato, Takayuki Shiraki, KyungHwa Park & Mitsugi Shimoda. (2010) Clinical Outcome of Hepatectomy for Hepatocellular Carcinomas ≤2 cm. World Journal of Surgery 35:2, pages 377-385.
Crossref
Crossref
Sonia Roman, Yasuhito Tanaka, Anis Khan, Fuat Kurbanov, Hideaki Kato, Masashi Mizokami & Arturo Panduro. (2010) Occult hepatitis B in the genotype H‐infected Nahuas and Huichol native Mexican population. Journal of Medical Virology 82:9, pages 1527-1536.
Crossref
Crossref
Marion Levast, Sylvie Larrat, Marie‐Ange Thelu, Sandrine Nicod, Agnès Plages, Alice Cheveau, Jean‐Pierre Zarski, Jean‐Marie Seigneurin, Patrice Morand & Vincent Leroy. (2010) Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin. Journal of Medical Virology 82:5, pages 747-754.
Crossref
Crossref